LGD-4033 - Odin Pharma

Ligandrol (LGD-4033) is a SARM that was introduced in the early 2010s by Ligand Pharmaceuticals. Unlike conventional steroids, it selectively activates androgen receptors in muscle and bone, aiming to preserve lean muscle mass while reducing androgenic side effects. Its initial development targeted conditions like muscle wasting and osteoporosis, but its anabolic properties quickly attracted attention in the bodybuilding community. Despite its muscle-preserving effects, LGD-4033 remains unapproved for medical use and continues to be classified as a research chemical.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about LGD-4033 by Odin Pharma, consult with your doctor or healthcare professional.